全球自然殺手細胞治療市場研究報告-產業分析、規模、佔有率、成長、趨勢和預測 2025 年至 2033 年

全球自然殺手細胞治療市場規模預計將從 2024 年的 37.7 億美元成長到 2033 年的 112.1 億美元，在 2026 年至 2033 年的預測期內呈現 12.87% 的強勁年複合成長率(CAGR)。

隨著人們越來越認知到 NK 細胞在癌症免疫治療中的作用，自然殺手 (NK) 細胞治療市場有望大幅成長。隨著研究人員不斷發現 NK 細胞在靶向和消除腫瘤細胞方面的潛力，對基於 NK 細胞的療法的需求正在激增。細胞療法的創新，包括工程化 NK 細胞和聯合療法的開發，正在增強這些治療的有效性，使其對醫療保健提供者和患者更具吸引力。

此外，對個人化醫療的日益重視正在影響 NK 細胞治療市場。隨著醫療保健提供者尋求根據個別患者情況量身定做治療方案，客製化 NK 細胞療法的需求正在上升。這一趨勢在血液系統惡性腫瘤和實體腫瘤的背景下尤其重要，個人化的治療方法可以改善治療結果並減少不良影響。

此外，對免疫療法研發的日益關注正在促進 NK 細胞治療市場的創新。生物製藥公司、研究機構和臨床中心之間的合作正在推動 NK 細胞技術和治療方法的進步，確保新產品滿足癌症患者不斷變化的需求。醫療專業人員和患者對 NK 細胞療法潛在益處的認知不斷提高，這也促進了市場擴張。總之，自然殺手細胞治療市場將實現強勁成長，其特點是技術進步、注重個人化治療方法以及致力於改善癌症治療。

我們的報告經過精心製作，為客戶提供有關各個行業和市場的全面且可操作的見解。每份報告都包含幾個關鍵部分，以確保徹底了解市場格局：

市場概覽：市場的詳細介紹，包括定義、分類和行業現狀概述。

市場動態：深入分析影響市場成長的關鍵促進因素、限制因素、機會與挑戰。本節探討技術進步、監管變化和新興趨勢等因素。

細分分析：根據產品類型、應用、最終用戶和地理位置等標準將市場細分為不同的細分市場。該分析強調了每個部分的表現和潛力。

競爭格局：對主要市場參與者的全面評估，包括其市場佔有率、產品組合、策略舉措和財務表現。本節深入介紹領先公司的競爭動態和關鍵策略。

市場預測：根據歷史資料和當前市場狀況，預測特定時期內的市場規模和成長趨勢。這包括定量分析和圖形表示來說明未來的市場軌跡。

區域分析：評估不同地理區域的市場表現，確定關鍵市場和區域趨勢。這有助於了解區域市場動態和機會。

新興趨勢與機會：識別當前和新興的市場趨勢、技術創新和潛在投資領域。本節提供未來市場發展和成長前景的見解。

目錄

第 1 章：前言

• 報告描述
  • 客觀的
  • 目標受眾
  • 獨特的銷售主張 (USP) 和產品
• 研究範圍
• 研究方法
  • 市場研究流程
  • 市場研究方法

第 2 章：執行摘要

• 市場亮點
• 全球市場概況

第 3 章：自然殺手細胞治療產業分析

• 簡介 - 市場動態
• 市場促進因素
• 市場限制
• 機會
• 產業趨勢
• 波特五力分析
• 市場吸引力分析
  • 治療學市場吸引力分析
  • 市場吸引力分析：按應用
  • 最終用戶的市場吸引力分析
  • 市場吸引力分析：按地區

第4章：價值鏈分析

• 價值鏈分析
• 原料分析
  • 原料清單
  • 原料製造商清單
  • 主要原物料價格走勢
• 潛在買家名單
• 行銷管道
  • 直效行銷
  • 間接行銷
  • 行銷通路發展趨勢

第 5 章：全球自然殺手細胞治療市場分析：依治療方式

• 治療學概述
• 治療學的歷史和預測數據分析
• NK 細胞定向抗體
• NK 細胞療法

第 6 章：全球自然殺手細胞治療市場分析：按應用

• 概述：按應用
• 歷史和預測數據分析：按應用
• 免疫增生性疾病
• 胃腸道疾病
• 癌症
• 其他

第 7 章：全球自然殺手細胞治療市場分析：按最終用戶

• 最終用戶概覽
• 最終用戶的歷史和預測數據分析
• 醫院
• 研究中心和研究所
• 其他

第 8 章：全球自然殺手細胞治療市場分析：按地區分類

• 區域展望
• 介紹
• 北美銷售分析
  • 概述、歷史和預測數據銷售分析
  • 北美各細分市場銷售分析
  • 北美各國銷售分析
  • 美國銷售分析
  • 加拿大銷售分析
  • 墨西哥銷售分析
• 歐洲銷售分析
  • 概述、歷史和預測數據銷售分析
  • 歐洲各細分市場銷售分析
  • 歐洲各國銷售分析
  • 英國銷售分析
  • 法國銷售分析
  • 德國銷售分析
  • 義大利銷售分析
  • 俄羅斯銷售分析
  • 歐洲其他地區銷售分析
• 亞太地區銷售分析
  • 概述、歷史和預測數據銷售分析
  • 亞太地區分部銷售分析
  • 亞太地區國家銷售分析
  • 中國銷售分析
  • 印度銷售分析
  • 日本銷售分析
  • 韓國銷售分析
  • 澳洲銷售分析
  • 東南亞銷售分析
  • 亞太地區其他地區銷售分析
• 拉丁美洲銷售分析
  • 概述、歷史和預測數據銷售分析
  • 拉丁美洲各細分市場銷售分析
  • 拉丁美洲各國銷售分析
  • 巴西銷售分析
  • 阿根廷銷售分析
  • 秘魯銷售分析
  • 智利銷售分析
  • 拉丁美洲其他地區銷售分析
• 中東和非洲銷售分析
  • 概述、歷史和預測數據銷售分析
  • 中東和非洲分部銷售分析
  • 中東和非洲國家銷售分析
  • 沙烏地阿拉伯銷售分析
  • 阿拉伯聯合大公國銷售分析
  • 以色列銷售分析
  • 南非銷售分析
  • 中東和非洲其他地區銷售分析

第 9 章：自然殺手細胞治療公司的競爭格局

• 自然殺手細胞治療市場競爭
• 夥伴關係/合作/協議
• 合併與收購
• 新產品發布
• 其他進展

第10章：公司簡介

• 頂級公司市佔率分析
• 市場集中度
• NKT Therapeutics Inc.
• 公司概況
• 公司收入
• 產品
• 最新動態
• Nkarta Therapeutics Inc.
• 公司概況
• 公司收入
• 產品
• 最新動態
• Nantkwest Inc.
• 公司概況
• 公司收入
• 產品
• 最新動態
• Innate Pharma SA
• 公司概況
• 公司收入
• 產品
• 最新動態
• Glycostem Therapeutics BV
• 公司概況
• 公司收入
• 產品
• 最新動態
• Fortress Biotech
• 公司概況
• 公司收入
• 產品
• 最新動態
• Fate Therapeutics
• 公司概況
• 公司收入
• 產品
• 最新動態
• Celgene Corporation
• 公司概況
• 公司收入
• 產品
• 最新動態
• Affimed NV
• 公司概況
• 公司收入
• 產品
• 最新動態
• Ziopharm Oncology Inc
• 公司概況
• 公司收入
• 產品
• 最新動態

注意 - 在公司簡介中，財務細節和最新發展取決於可用性，對於私人公司，可能不予涵蓋

Global Natural Killer Cells Therapeutics Market size is anticipated to grow from USD 3.77 Billion in 2024 to USD 11.21 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 12.87% during the forecast period of 2026 to 2033.

The natural killer (NK) cells therapeutics market is poised for significant growth, driven by the increasing recognition of the role of NK cells in cancer immunotherapy. As researchers continue to uncover the potential of NK cells in targeting and eliminating tumor cells, the demand for NK cell-based therapies is surging. Innovations in cell therapy, including the development of engineered NK cells and combination therapies, are enhancing the effectiveness of these treatments, making them more appealing to healthcare providers and patients.

Moreover, the growing emphasis on personalized medicine is influencing the NK cells therapeutics market. As healthcare providers seek to tailor treatments to individual patient profiles, the demand for customized NK cell therapies is rising. This trend is particularly relevant in the context of hematological malignancies and solid tumors, where personalized approaches can improve treatment outcomes and reduce adverse effects.

Furthermore, the increasing focus on research and development in immunotherapy is fostering innovation in the NK cells therapeutics market. Collaborations between bi opharmaceutical companies, research institutions, and clinical centers are driving advancements in NK cell technologies and treatment methodologies, ensuring that new products meet the evolving needs of cancer patients. The growing awareness of the potential benefits of NK cell therapies among healthcare professionals and patients is also contributing to market expansion. In summary, the natural killer cells therapeutics market is set for robust growth, characterized by technological advancements, a focus on personalized treatment approaches, and a commitment to improving cancer care.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Therapeutics

• NK Cell Directed Antibodies
• NK Cell Therapies

By Application

• Immunoproliferative Disorders
• Gastrointestinal Diseases
• Cancer
• Other

By End User

• Hospitals
• Research Centers & Institutes
• Other
• COMPANIES PROFILED
• NKT Therapeutics Inc.
• Nkarta Therapeutics Inc.
• Nantkwest Inc.
• Innate Pharma S.A.
• Glycostem Therapeutics BV
• Fortress Biotech
• Fate Therapeutics
• Celgene Corporation
• Affimed N.V.
• Ziopharm Oncology Inc.
• The above list can be customized.

TABLE OF CONTENTS

1. PREFACE

• 1.1. Report Description
  • 1.1.1 Objective
  • 1.1.2 Target Audience
  • 1.1.3 Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1 Market Research Process
  • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3. NATURAL KILLER CELLS THERAPEUTICS INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porters Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Therapeutics
  • 3.7.2 Market Attractiveness Analysis By Application
  • 3.7.3 Market Attractiveness Analysis By End User
  • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1 List of Raw Materials
  • 4.2.2 Raw Material Manufactures List
  • 4.2.3 Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1 Direct Marketing
  • 4.4.2 Indirect Marketing
  • 4.4.3 Marketing Channel Development Trend

5. GLOBAL NATURAL KILLER CELLS THERAPEUTICS MARKET ANALYSIS BY THERAPEUTICS

• 5.1. Overview By Therapeutics
• 5.2. Historical and Forecast Data Analysis By Therapeutics
• 5.3. NK Cell Directed Antibodies Historic and Forecast Sales By Regions
• 5.4. NK Cell Therapies Historic and Forecast Sales By Regions

6. GLOBAL NATURAL KILLER CELLS THERAPEUTICS MARKET ANALYSIS BY APPLICATION

• 6.1. Overview By Application
• 6.2. Historical and Forecast Data Analysis By Application
• 6.3. Immunoproliferative Disorders Historic and Forecast Sales By Regions
• 6.4. Gastrointestinal Diseases Historic and Forecast Sales By Regions
• 6.5. Cancer Historic and Forecast Sales By Regions
• 6.6. Other Historic and Forecast Sales By Regions

7. GLOBAL NATURAL KILLER CELLS THERAPEUTICS MARKET ANALYSIS BY END USER

• 7.1. Overview By End User
• 7.2. Historical and Forecast Data Analysis By End User
• 7.3. Hospitals Historic and Forecast Sales By Regions
• 7.4. Research Centers & Institutes Historic and Forecast Sales By Regions
• 7.5. Other Historic and Forecast Sales By Regions

8. GLOBAL NATURAL KILLER CELLS THERAPEUTICS MARKET ANALYSIS BY GEOGRAPHY

• 8.1. Regional Outlook
• 8.2. Introduction
• 8.3. North America Sales Analysis
  • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.3.2 North America By Segment Sales Analysis
  • 8.3.3 North America By Country Sales Analysis
  • 8.3.4 United States Sales Analysis
  • 8.3.5 Canada Sales Analysis
  • 8.3.6 Mexico Sales Analysis
• 8.4. Europe Sales Analysis
  • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.4.2 Europe By Segment Sales Analysis
  • 8.4.3 Europe By Country Sales Analysis
  • 8.4.4 United Kingdom Sales Analysis
  • 8.4.5 France Sales Analysis
  • 8.4.6 Germany Sales Analysis
  • 8.4.7 Italy Sales Analysis
  • 8.4.8 Russia Sales Analysis
  • 8.4.9 Rest Of Europe Sales Analysis
• 8.5. Asia Pacific Sales Analysis
  • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.5.2 Asia Pacific By Segment Sales Analysis
  • 8.5.3 Asia Pacific By Country Sales Analysis
  • 8.5.4 China Sales Analysis
  • 8.5.5 India Sales Analysis
  • 8.5.6 Japan Sales Analysis
  • 8.5.7 South Korea Sales Analysis
  • 8.5.8 Australia Sales Analysis
  • 8.5.9 South East Asia Sales Analysis
  • 8.5.10 Rest Of Asia Pacific Sales Analysis
• 8.6. Latin America Sales Analysis
  • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.6.2 Latin America By Segment Sales Analysis
  • 8.6.3 Latin America By Country Sales Analysis
  • 8.6.4 Brazil Sales Analysis
  • 8.6.5 Argentina Sales Analysis
  • 8.6.6 Peru Sales Analysis
  • 8.6.7 Chile Sales Analysis
  • 8.6.8 Rest of Latin America Sales Analysis
• 8.7. Middle East & Africa Sales Analysis
  • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.7.2 Middle East & Africa By Segment Sales Analysis
  • 8.7.3 Middle East & Africa By Country Sales Analysis
  • 8.7.4 Saudi Arabia Sales Analysis
  • 8.7.5 UAE Sales Analysis
  • 8.7.6 Israel Sales Analysis
  • 8.7.7 South Africa Sales Analysis
  • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE NATURAL KILLER CELLS THERAPEUTICS COMPANIES

• 9.1. Natural Killer Cells Therapeutics Market Competition
• 9.2. Partnership/Collaboration/Agreement
• 9.3. Merger And Acquisitions
• 9.4. New Product Launch
• 9.5. Other Developments

10. COMPANY PROFILES OF NATURAL KILLER CELLS THERAPEUTICS INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Market Concentration Rate
• 10.3. NKT Therapeutics Inc.
  • 10.3.1 Company Overview
  • 10.3.2 Company Revenue
  • 10.3.3 Products
  • 10.3.4 Recent Developments
• 10.4. Nkarta Therapeutics Inc.
  • 10.4.1 Company Overview
  • 10.4.2 Company Revenue
  • 10.4.3 Products
  • 10.4.4 Recent Developments
• 10.5. Nantkwest Inc.
  • 10.5.1 Company Overview
  • 10.5.2 Company Revenue
  • 10.5.3 Products
  • 10.5.4 Recent Developments
• 10.6. Innate Pharma S.A.
  • 10.6.1 Company Overview
  • 10.6.2 Company Revenue
  • 10.6.3 Products
  • 10.6.4 Recent Developments
• 10.7. Glycostem Therapeutics BV
  • 10.7.1 Company Overview
  • 10.7.2 Company Revenue
  • 10.7.3 Products
  • 10.7.4 Recent Developments
• 10.8. Fortress Biotech
  • 10.8.1 Company Overview
  • 10.8.2 Company Revenue
  • 10.8.3 Products
  • 10.8.4 Recent Developments
• 10.9. Fate Therapeutics
  • 10.9.1 Company Overview
  • 10.9.2 Company Revenue
  • 10.9.3 Products
  • 10.9.4 Recent Developments
• 10.10. Celgene Corporation
  • 10.10.1 Company Overview
  • 10.10.2 Company Revenue
  • 10.10.3 Products
  • 10.10.4 Recent Developments
• 10.11. Affimed N.V.
  • 10.11.1 Company Overview
  • 10.11.2 Company Revenue
  • 10.11.3 Products
  • 10.11.4 Recent Developments
• 10.12. Ziopharm Oncology Inc
  • 10.12.1 Company Overview
  • 10.12.2 Company Revenue
  • 10.12.3 Products
  • 10.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

• Market Snapshot
• Drivers: Impact Analysis
• Restraints: Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• Analysis By Therapeutics (USD MN)
• NK Cell Directed Antibodies Market Sales By Geography (USD MN)
• NK Cell Therapies Market Sales By Geography (USD MN)
• Analysis By Application (USD MN)
• Immunoproliferative Disorders Market Sales By Geography (USD MN)
• Gastrointestinal Diseases Market Sales By Geography (USD MN)
• Cancer Market Sales By Geography (USD MN)
• Other Market Sales By Geography (USD MN)
• Analysis By End User (USD MN)
• Hospitals Market Sales By Geography (USD MN)
• Research Centers & Institutes Market Sales By Geography (USD MN)
• Other Market Sales By Geography (USD MN)
• Global Natural Killer Cells Therapeutics Market Sales By Geography (USD MN)
• North America Market Analysis (USD MN)
• United States Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate By Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• South East Asia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of Natural Killer Cells Therapeutics Report
• Market Research Process
• Market Research Methodology
• Global Natural Killer Cells Therapeutics Market Size, By Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis By Therapeutics
• Market Attractiveness Analysis By Application
• Market Attractiveness Analysis By End User
• Market Attractiveness Analysis By Region
• Value Chain Analysis
• Global Market Analysis By Therapeutics (USD MN)
• NK Cell Directed Antibodies Market Sales By Geography (USD MN)
• NK Cell Therapies Market Sales By Geography (USD MN)
• Global Market Analysis By Application (USD MN)
• Immunoproliferative Disorders Market Sales By Geography (USD MN)
• Gastrointestinal Diseases Market Sales By Geography (USD MN)
• Cancer Market Sales By Geography (USD MN)
• Other Market Sales By Geography (USD MN)
• Global Market Analysis By End User (USD MN)
• Hospitals Market Sales By Geography (USD MN)
• Research Centers & Institutes Market Sales By Geography (USD MN)
• Other Market Sales By Geography (USD MN)
• Global Market Sales (USD MN)
• North America Market Sales (USD MN)
• Europe Market Sales (USD MN)
• Asia Pacific Market Sales (USD MN)
• Latin America Market Sales (USD MN)
• Middle East & Africa Market Sales (USD MN)
• Recent Development in Industry
• Top Company Market Share Analysis
• Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.